8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): May 24, 2016

 

 

ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-35547   36-4392754
(State or Other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)

222 Merchandise Mart Plaza, Suite 2024, Chicago, Illinois 60654

(Address of Principal Executive Offices) (Zip Code)

Registrant’s Telephone Number, Including Area Code: (312) 506-1200

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders

At the 2016 Annual Meeting held on May 24, 2016, the stockholders of the Company voted on the following three proposals and cast their votes as described below:

1. The individuals listed below were elected at the 2016 Annual Meeting to serve as directors of the Company until the next annual meeting of stockholders and until their successors are duly elected and qualified.

 

     For      Against      Abstain      Broker Non-Vote  

Paul M. Black

     159,882,315         988,606         26,257         9,824,424   

Greg Garrison

     160,131,675         736,613         28,890         9,824,424   

Jonathan J. Judge

     160,062,099         805,483         29,596         9,824,424   

Michael A. Klayko

     158,200,909         2,667,054         29,215         9,824,424   

Yancey L. Spruill

     160,062,130         805,249         29,799         9,824,424   

Dave B. Stevens

     159,801,365         1,066,062         29,751         9,824,424   

David D. Stevens

     146,654,203         14,213,610         29,365         9,824,424   

Ralph H. Thurman

     159,772,906         1,094,416         29,856         9,824,424   

2. A management proposal to ratify the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016, as described in the proxy materials, was approved.

 

For   Against   Abstain   Broker Non-Vote

170,624,507

  57,894   39,201   0

3. A non-binding, advisory resolution to approve named executive compensation, as described in the proxy materials, was approved.

 

For   Against   Abstain   Broker Non-Vote

157,602,951

  3,202,177   92,050   9,824,424


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.

Date: May 25, 2016

    By:   /s/ Brian P. Farley
      Brian P. Farley
      SVP, General Counsel and Corporate Secretary